Prescription Audit in OPD of NABH & JCI Approved Hospital in Capital Territory of India

Quality of Life Clinical Trial

Official title:

A Prescription Audit In The Outpatient Department Of Nabh & Jci Approved Super Speciality Hospital In The Capital Territory Of India

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05729412
• Other study ID #: MAX/IEC/2022/NOV/PA01
• Status: Completed
• Start date: November 1, 2022
• Est. completion date: January 1, 2023

Study information

• Verified date: June 2023
• Source: Kakatiya University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient.

Need of study:

For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve quality standards and quality of care For implication of professional practices To identify and eliminate deficient practice

Objectives:

1. To study the quality of good prescription

2. In minimization of prescription errors and medication errors

3. Also to comply with good clinical practice

4. Enhancement of patient safety

5. In the maintenance of rational prescribing

6. To study the quality of care provided by the hospital to the patient

Plan of study:

• To select the patient based on inclusion and exclusion criteria

• To collect the information from OP's prescription

• To identify prescribing errors and medication error

• To study the management of good prescription

Study Sites: Max Super Speciality Hospital, Saket, New Delhi (INDIA) Study Design:

Observational cohort study Study Duration: 1 month (November 2022)

Description:

Source of the data: Review of out-patient prescription Sample size: 100 prescription

Possible outcomes:

Minimization of prescribing errors It improves the quality of care Enhancement of patient safety Compliance with good clinical practice In the maintenance of rational prescribing

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: January 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Participants who are willing to participate.

• Participants who are attending in the out-patient department.

• Participants reported during the study period.

• Participants who have a prescription which is legible and complete.

Exclusion Criteria:

• Participants who are unwilling to provide the required information.

• Participants who are not attending the out-patient department.

• Participants whose prescription is not legible and competent

Related Conditions & MeSH terms

• Quality of Life

Intervention

Other:
• Mentioned
If prescription is properly filled for specific details than it is compliance

Locations

Country	Name	City	State
India	Max Super Speciality Hospital	New Delhi	Delhi

Sponsors (1)

Lead Sponsor	Collaborator
Kakatiya University

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of prescription	Data is available sufficient	November 01, 2022 to November 30, 2022